Method of isolating and detecting cancer stem cells
AssigneeSylvain Gnaho
InventorsVincent Carre, Aurélie Lacroix
Life of this patent
Estimating the term…
Loading patent…
AssigneeSylvain Gnaho
InventorsVincent Carre, Aurélie Lacroix
Estimating the term…
Disclosed is the in vitro use of at least one lectin which recognises the fucose alpha(1-2) galactose unit for labelling cancer stem cells of organs involved in respiration, in order to obtain labelled cancer stem cells of organs involved in respiration, in a biological sample. In one particular embodiment, the at least one lectin is chosen from the lectins Ulex Europaeus agglutinin 1 (UEA-1) or the homologue thereof, Trichosanthes japonica agglutinin II (TJA-II), Agaricus Bisporus agglutinin (ABA), Amaranthus Caudatus agglutinin (ACA), jacalin, Griffonia Simplicifolia lectin I (GSL-I) and Griffonia Simplicifolia lectin II (GSL-II). In one particular embodiment, the organ involved in respiration is chosen from the lungs, the larynx, the pharynx, the mouth, the nose, the throat, the tongue, the sinuses, the trachea and the saliva glands including the tonsils and the parotid gland.
An in vitro method for isolating cancer stem cells of organs involved in respiration in a biological sample comprising:
Method of making an isolated population of cancer stem cells, comprising
Dependencies are inferred from the claim text.